Adma Biologics (ADMA) Total Debt Growth (5y) (2017 - 2025)
Adma Biologics (ADMA) Total Debt Growth (5y) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Adma Biologics | 1.99 Bn | 1.91 Bn | 88.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4.95% |
| Sep 30, 2025 | -3.15% |
| Mar 31, 2025 | -2.24% |
| Dec 31, 2024 | 37.15% |
| Sep 30, 2024 | 8.35% |
| Jun 30, 2024 | 54.50% |
| Mar 31, 2024 | 54.46% |
| Dec 31, 2023 | 34.20% |
| Sep 30, 2023 | 40.27% |
| Jun 30, 2023 | 56.69% |
| Mar 31, 2023 | 120.63% |
| Dec 31, 2022 | 120.18% |
| Sep 30, 2022 | 56.97% |
| Jun 30, 2022 | 71.73% |
| Mar 31, 2022 | 66.42% |
| Dec 31, 2021 | 36.53% |
| Dec 31, 2020 | 45.52% |
| Dec 31, 2019 | 0.46% |
| Mar 31, 2018 | -10.45% |
| Dec 31, 2017 | -6.06% |